Authors:
Scholz, M
Kraft, HG
Lingenhel, A
Delport, R
Vorster, EH
Bickeboller, H
Utermann, G
Citation: M. Scholz et al., Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians, EUR J HUM G, 7(2), 1999, pp. 169-178
Authors:
Silahtaroglu, A
Hol, FA
Jensen, PKA
Erdel, M
Duba, HC
Geurds, MPA
Knoers, NVAM
Mariman, ECM
Tumer, Z
Utermann, G
Wirth, J
Bugge, M
Tommerup, N
Citation: A. Silahtaroglu et al., Molecular cytogenetic detection of 9q34 breakpoints associated with nail patella syndrome, EUR J HUM G, 7(1), 1999, pp. 68-76
Citation: M. Ogorelkova et al., Molecular basis of congenital Lp(a) deficiency: a frequent apo(a) 'null' mutation in Caucasians, HUM MOL GEN, 8(11), 1999, pp. 2087-2096
Authors:
Fitzky, BU
Glossmann, H
Utermann, G
Moebius, FF
Citation: Bu. Fitzky et al., Molecular genetics of the Smith-Lemli-Opitz syndrome and postsqualene sterol metabolism, CURR OP LIP, 10(2), 1999, pp. 123-131
Authors:
Verdorfer, I
Hobisch, A
Hittmair, A
Duba, HC
Bartsch, G
Utermann, G
Erdel, M
Citation: I. Verdorfer et al., Cytogenetic characterization of 22 human renal cell tumors in relation to a histopathological classification, CANC GENET, 111(1), 1999, pp. 61-70
Authors:
Kerschdorfer, L
Konig, P
Neyer, U
Bosmuller, C
Lhotta, K
Auinger, M
Hohenegger, M
Riegler, P
Margreiter, R
Utermann, G
Dieplinger, H
Kronenberg, F
Citation: L. Kerschdorfer et al., Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up, ATHEROSCLER, 144(2), 1999, pp. 381-391
Authors:
Ghaffari-Tabrizi, N
Bauer, B
Villunger, A
Baier-Bitterlich, G
Altman, A
Utermann, G
Uberall, F
Baier, G
Citation: N. Ghaffari-tabrizi et al., Protein kinase C theta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells, EUR J IMMUN, 29(1), 1999, pp. 132-142
Authors:
Kronenberg, F
Auinger, M
Trenkwalder, E
Irsigler, K
Utermann, G
Dieplinger, H
Citation: F. Kronenberg et al., Is apolipoprotein(a) a susceptibility gene for Type I diabetes mellitus and related to long-term survival?, DIABETOLOG, 42(8), 1999, pp. 1021-1027
Authors:
Kronenberg, F
Kronenberg, MF
Kiechl, S
Trenkwalder, E
Santer, P
Oberhollenzer, F
Egger, G
Utermann, G
Willeit, J
Citation: F. Kronenberg et al., Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis - Prospective results from the Bruneck study, CIRCULATION, 100(11), 1999, pp. 1154-1160
Authors:
Culig, Z
Hoffmann, J
Erdel, M
Eder, IE
Hobisch, A
Hittmair, A
Bartsch, G
Utermann, G
Schneider, MR
Parczyk, K
Klocker, H
Citation: Z. Culig et al., Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system, BR J CANC, 81(2), 1999, pp. 242-251
Authors:
Krings, M
Salem, AH
Bauer, K
Geisert, H
Malek, AK
Chaix, L
Simon, C
Welsby, D
Di Rienzo, A
Utermann, G
Sajantila, A
Paabo, S
Stoneking, M
Citation: M. Krings et al., mtDNA analysis of Nile River Valley populations: A genetic corridor or a barrier to migration, AM J HU GEN, 64(4), 1999, pp. 1166-1176